SOURCE: Franek Technologies, Inc.

October 30, 2006 08:00 ET

XDx Selects Franek Technologies to Protect $900,000 in Instrumentation Enabling Revolutionary Post-Cardiac Transplant Rejection Monitoring

Conducting Next Generation, Non-Invasive Post-Cardiac Transplant Research, XDx Proactively Implements Customized, Instrumentation-Grade Power Protection to Safeguard Irreplaceable Patient Samples

TUSTIN, CA -- (MARKET WIRE) -- October 30, 2006 -- Franek Technologies, Inc., the leader in certified Category III-3 Laboratory Battery Backup Power Protection Systems (LPS/UPS), has been selected to protect XDx's $900,000 investment in Applied Biosystems 7900 Sequence Detection Systems used in the company's post-cardiac transplant rejection monitoring research. Based on past experience with brownouts at its research facilities, XDx proactively sought the higher-level power protection offered by Franek Technologies to protect not only its substantial investment in instrumentation, but most importantly, the irreplaceable patient samples that are paramount to testing for acute cellular rejection in post-cardiac transplant patients.

XDx has pioneered AlloMap® molecular expression testing, which is a non-invasive method for determining the risk of rejection in heart transplant recipients. The patient samples processed at the XDx clinical and research laboratories are irreplaceable as they are collected from a patient at a precise moment in time that is defined by the patient's medical condition. Should a power outage occur during a test run, which typically lasts just under 2 hours, the sample and all related data are lost without another blood draw and test rerun. Because the success of AlloMap testing relies on consistent and accurate data, XDx recognized the importance of implementing the higher level of power protection provided by Franek Technologies for all its ABI instrumentation systems. Since installation, the protected systems have not lost a single patient sample due to power irregularities.

"With Franek Technologies' power protection systems in place, we don't have to worry about the brownouts that we know are going to occur in our labs," explains Elizabeth King, Research Specialist, XDx. "We made sure that our instruments were going to run smoothly 24/7, before experiencing any problems. We can now run tests, even over the weekend, without a second thought. Having this peace of mind allows us to focus on what's really important, our research and ultimately, the long-term health of post-cardiac transplant patients."

"We are proud of the relationship that we have with XDx, which dates back to 2003," says Raymond L. Hecker, VP, Franek Technologies. "The company's researchers realize the real risks posed by unconditioned power and have proactively taken steps to protect their instruments and samples. We couldn't be happier that they have not experienced a single power-related loss on their protected systems. We look forward to providing more power protection solutions for both their clinical and research labs in the future."

Founded in 2000, XDx is a molecular diagnostics company based in South San Francisco, Calif. Setting the stage for a new era in personalized medicine, XDx is one of the first companies to develop and commercialize practical applications built on insights from the Human Genome Project. The company has developed a proprietary new method for non-invasively monitoring the immune system by measuring gene expression in a patient's peripheral blood. The technology offers the potential to decrease healthcare costs and significantly improve the quality of life for patients with a variety of life-threatening or life-altering, immune-mediated diseases. More information can be found at www.xdx.com.

Franek Technologies, Inc. specializes in providing Laboratory Productivity/Protection Systems (LPS/UPS) for analytical, diagnostics, forensic, life-science, pharmaceutical and biotechnology instrumentation systems applications. Its certified uninterruptible battery backup power sources for laboratory and instrumentation applications protect over $3 billion in laboratory assets worldwide. The company's power engineers have developed LPS/UPS products for over 1,500 instrumentation applications, from more than 80 manufacturers, to meet US Government power requirements. For more information, call (800) 326-6480 or visit www.franek.com.

Contact Information

  • Contact:
    Jeanna Sanchez
    JCS Public Relations
    Tel: (760) 295-4166
    Email Contact

    Ray Hecker
    Franek Technologies, Inc.
    Tel: +1 (800) 326-6480
    Email Contact